Last time I interviewed BioViva CEO Liz Parrish I had no idea that she would make global headlines shortly thereafter by becoming a gene therapy test subject herself. And so I wanted to bring her back to discuss the kind of experiment she volunteered for, as well as the broad science behind it. So, 4 months after receiving gene therapies aimed at reversing muscle-wasting disease and aging, I finally managed to get Liz on my podcast.
During our 60 min conversation with Liz Parrish we cover a variety of interesting topics such as: why she decided to target these particular conditions – sarcopenia and aging; why Parrish thinks that testing them both at once is a good thing; the best and worst case outcome scenarios; the test protocol and timeline for any definitive results, as well as the potential biomarkers that can confirm or deny the efficacy of these therapies; the costs associated with such treatments and why insurance companies and governments will have an incentive to pay; Zoltan Istvan’s presidential candidacy and his campaign against death; her take on CRISPR and gene editing…
As always you can listen to or download the audio file above or scroll down and watch the video interview in full. To show your support you can write a review on iTunes, make a direct donation or become a patron on Patreon.
Who is Liz Parrish?
BioViva‘s CEO Elizabeth Parrish is a humanitarian, entrepreneur and innovator, as well as a leading voice for genetic cures. As a strong proponent of progress and education for the advancement of regenerative medicine modalities, she serves as a motivational speaker to the public at large for the life sciences. She is actively involved in international educational media outreach and sits on the board of the International Longevity Alliance (ILA). Liz is an affiliated member of the Complex Biological Systems Alliance (CBSA), which is a unique platform for mensa based, highly gifted persons who advance scientific discourse and discovery. The mission of the CBSA is to further scientific understanding of biological complexity and the nature and origins of human disease. Parrish is the founder of BioTrove Investments LLC and the BioTrove Podcasts which is committed to offering a meaningful way for people to learn about and fund research in regenerative medicine. She is also the Secretary of The American Longevity Alliance (ALA) a 501(c)(3) nonprofit trade association that brings together individuals, companies, and organizations who work in advancing the emerging field of cellular & regenerative medicine.